After two decades of dedicated studies, in 2022, Ascherio and colleagues have provided the most definitive and compelling evidence that Epstein–Barr virus (EBV) is an early and essential factor in MS development. Now, the crux of MS research is to find out how a ubiquitous, generally asymptomatic infection interacts with genetic and environmental cofactors to induce disease in a minority of people.
EBV infection drives MS pathology: Yes / Aloisi, Francesca; Salvetti, Marco. - In: MULTIPLE SCLEROSIS. - ISSN 1477-0970. - 30:4-5(2024), pp. 483-485. [10.1177/13524585241235825]
EBV infection drives MS pathology: Yes
Aloisi, Francesca
;Salvetti, Marco
2024
Abstract
After two decades of dedicated studies, in 2022, Ascherio and colleagues have provided the most definitive and compelling evidence that Epstein–Barr virus (EBV) is an early and essential factor in MS development. Now, the crux of MS research is to find out how a ubiquitous, generally asymptomatic infection interacts with genetic and environmental cofactors to induce disease in a minority of people.File allegati a questo prodotto
| File | Dimensione | Formato | |
|---|---|---|---|
|
Aloisi_EBV-infection_2024.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
127.79 kB
Formato
Adobe PDF
|
127.79 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
